Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Aug;34(8):1405-9.
doi: 10.1007/s11064-009-9925-8. Epub 2009 Feb 18.

Altered postsynaptic-density-levels of caldendrin in the para-chloroamphetamine-induced serotonin syndrome but not in the rat ketamine model of psychosis

Affiliations

Altered postsynaptic-density-levels of caldendrin in the para-chloroamphetamine-induced serotonin syndrome but not in the rat ketamine model of psychosis

Karl-Heinz Smalla et al. Neurochem Res. 2009 Aug.

Abstract

Caldendrin is a synaptic calcium sensor protein that is tightly associated with the postsynaptic density (PSD). Previous work has shown that the association of the protein with the synapse is highly dynamic and is increased in an activity-dependent manner. In the present study the caldendrin-association with the postsynaptic cytomatrix was analyzed in animal models of psychosis and drug abuse induced neurotoxicity. Subchronic administration of the N-methyl-D-aspartate (NMDA)-receptor antagonist ketamine, serving as a model of NMDA-receptor hypofunction and schizophrenia showed no significant effect on the PSD-levels of caldendrin, indicating that NMDA-receptor activity is not required to keep caldendrin at the synapse. However, administration of high doses of the serotonergic neurotoxin p-chloroamphetamine (PCA) lead to significant changes in the association of caldendrin with the PSD. These results underscore the dynamic association of caldendrin with the PSD and suggest a role of this synaptic calcium sensor in the PCA-induced serotonin syndrome.

PubMed Disclaimer

References

    1. Curr Opin Pharmacol. 2007 Feb;7(1):48-55 - PubMed
    1. Brain Res Brain Res Rev. 2003 Sep;43(1):70-84 - PubMed
    1. Mol Psychiatry. 2008 Sep;13(9):878-96 - PubMed
    1. Mol Psychiatry. 2009 Jun;14(6):601-13 - PubMed
    1. Annu Rev Pharmacol Toxicol. 2002;42:165-79 - PubMed

Publication types

LinkOut - more resources